JFL Life

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE0LA901015
NSEID: JFLLIFE
BSEID:

INR

11.90

0.5 (4.39%)

BSENSE

Dec 05

BSE+NSE Vol: 36000

{
  "main_header": {
    "sid": 1003691,
    "name": "JFL Life",
    "stock_name": "JFL Life",
    "full_name": "JFL Life Sciences Ltd",
    "name_url": "stocks-analysis/jfl-life",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "11.90",
    "chg": 0.5,
    "chgp": "4.39%",
    "dir": 1,
    "prev_price": "11.40",
    "mcapval": "38.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "JFLLIFE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0LA901015",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": 36000,
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jfl-life-1003691-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "JFL Life Sciences Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jfl-life-sciences-hits-upper-circuit-amid-strong-buying-pressure-3749080",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JFLLifeSciences_stocks_hitting_upper_circuit_3749080.png",
        "date": "2025-12-05 14:00:12",
        "description": "JFL Life Sciences Ltd witnessed a significant surge in its share price on 5 Dec 2025, hitting the upper circuit limit of 5%, closing at ₹11.95. This movement was driven by robust buying interest, resulting in a maximum daily gain of 4.82%, outperforming its sector and broader market indices."
      },
      {
        "title": "JFL Life Sciences Hits Upper Circuit Amidst Unprecedented Buying Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jfl-life-sciences-hits-upper-circuit-amidst-unprecedented-buying-interest-3749025",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JFLLifeSciences_only_buyers_3749025.png",
        "date": "2025-12-05 13:26:12",
        "description": "JFL Life Sciences Ltd witnessed extraordinary buying momentum on 5 Dec 2025, hitting the upper circuit with only buy orders in the queue and no sellers present. This rare market phenomenon signals intense demand and the possibility of a multi-day circuit scenario, drawing significant attention from investors and market watchers alike."
      },
      {
        "title": "JFL Life Sciences Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jfl-life-sciences-faces-severe-selling-pressure-hits-lower-circuit-amid-market-downturn-3729249",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JFLLifeSciences_only_sellers_3729249.png",
        "date": "2025-11-25 15:31:01",
        "description": "JFL Life Sciences Ltd has encountered significant selling pressure, with the stock registering a sharp decline and exhibiting a complete absence of buyers on the trading day. The pharmaceutical and biotechnology company’s shares have been under sustained downward momentum, reflecting distress selling signals and a challenging market environment."
      },
      {
        "title": "Why is JFL Life falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-jfl-life-fallingrising-3722294",
        "imagepath": "",
        "date": "2025-11-22 01:28:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>JFL Life Sciences has experienced a sharp downturn in its stock price over the past year, with a decline of 62.96%, starkly contrasting with the Sensex’s gain of 11.64% during the same period. The stock’s performance over three years is even more concerning, showing a 70.24% loss while the benchmark index surged by 43.55%. This persistent underperformance highlights investor scepticism about the company’s growth prospects and operational efficiency.</p>\n<p>In the short term, the stock has also struggled, falling 6.72% in the last week compared to a modest 0.61% rise in the Sensex. Despite a slight positive return of 1.63% over the past month, this is only marginally better than the benchmark’s 0.77% gain, indicating limited investor..."
      },
      {
        "title": "JFL Life Sciences Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jfl-life-sciences-hits-lower-circuit-amid-heavy-selling-pressure-3720692",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JFLLifeSciences_stocks_hitting_lower_circuit_3720692.png",
        "date": "2025-11-21 11:00:15",
        "description": "Shares of JFL Life Sciences Ltd plunged to their lower circuit limit on 21 Nov 2025, reflecting intense selling pressure and a sharp decline of 5.04% in a single trading session. The stock closed at ₹12.25, matching its intraday low and moving closer to its 52-week low, signalling heightened investor caution in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "JFL Life Sciences Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jfl-life-sciences-faces-severe-selling-pressure-hits-lower-circuit-amid-market-turmoil-3720636",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JFLLifeSciences_only_sellers_3720636.png",
        "date": "2025-11-21 10:50:56",
        "description": "JFL Life Sciences Ltd is experiencing severe selling pressure, with the stock hitting a lower circuit and an absence of buyers on the trading floor. The pharmaceutical and biotechnology company’s shares have recorded consecutive losses across multiple time frames, signalling distress selling and a challenging market environment."
      },
      {
        "title": "JFL Life Sciences Hits Lower Circuit Limit, Closes at Rs 12.75 Amid Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jfl-life-sciences-hits-lower-circuit-limit-closes-at-rs-1275-amid-decline-3706814",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JFLLifeSciences_stocks_hitting_lower_circuit_3706814.png",
        "date": "2025-11-17 10:00:32",
        "description": "JFL Life Sciences Ltd faced notable trading activity as its stock hit the lower circuit limit, closing at Rs 12.75. The total traded volume was 0.06 lakh shares, with a significant decline in investor participation. The stock is currently underperforming compared to its sector and trading below key moving averages."
      },
      {
        "title": "How has been the historical performance of JFL Life?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-jfl-life-3695714",
        "imagepath": "",
        "date": "2025-11-13 00:36:37",
        "description": "Answer:\nThe historical performance of JFL Life shows a significant upward trend in net sales and profitability over the years.\n\nBreakdown:\nJFL Life's net sales have increased from 30.17 Cr in Mar'20 to 82.04 Cr in Mar'25, reflecting a strong growth trajectory. Total operating income followed a similar pattern, rising from 30.17 Cr in Mar'20 to 82.04 Cr in Mar'25. The raw material costs also rose, from 26.72 Cr in Mar'20 to 66.77 Cr in Mar'25, indicating increased production expenses. Operating profit, excluding other income, improved from 1.86 Cr in Mar'20 to 8.19 Cr in Mar'25, while profit before tax increased from 0.50 Cr to 6.14 Cr in the same period. Profit after tax also saw a rise from 0.36 Cr in Mar'20 to 4.16 Cr in Mar'25. The company's total assets grew from 48.26 Cr in Mar'22 to 71.91 Cr in Mar'25, with total liabilities increasing from 48.26 Cr to 71.91 Cr. Cash flow from operating activities sho..."
      },
      {
        "title": "How has been the historical performance of JFL Life?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-jfl-life-3694960",
        "imagepath": "",
        "date": "2025-11-13 00:01:57",
        "description": "Answer:\nThe historical performance of JFL Life shows a significant growth trend in net sales and profitability over the past few years.\n\nBreakdown:\nJFL Life's net sales have increased from 30.17 Cr in Mar'20 to 82.04 Cr in Mar'25, indicating a robust growth trajectory. Total operating income has followed a similar pattern, rising from 30.17 Cr to 82.04 Cr during the same period. The company's total expenditure, excluding depreciation, has also grown, reaching 73.85 Cr in Mar'25 from 28.31 Cr in Mar'20. Operating profit, which reflects the company's operational efficiency, has improved from 1.86 Cr in Mar'20 to 8.20 Cr in Mar'25, while profit before tax has increased from 0.50 Cr to 6.14 Cr in the same timeframe. Profit after tax has also seen a rise from 0.36 Cr in Mar'20 to 4.16 Cr in Mar'25. The company's earnings per share (EPS) have fluctuated, peaking at 10.8 in Mar'21 before settling at 1.26 in Mar'25..."
      }
    ],
    "total": 110,
    "sid": "1003691",
    "stock_news_url": "https://www.marketsmojo.com/news/jfl-life-sciences-1003691"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "JFL Life Sciences Ltd has declared <strong>2%</strong> dividend, ex-date: 13 Sep 24",
          "dt": "2024-09-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "JFL Life Sciences Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 24 Sep 24",
          "dt": "2024-09-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

JFL Life Sciences Hits Upper Circuit Amid Strong Buying Pressure

2025-12-05 14:00:12

JFL Life Sciences Ltd witnessed a significant surge in its share price on 5 Dec 2025, hitting the upper circuit limit of 5%, closing at ₹11.95. This movement was driven by robust buying interest, resulting in a maximum daily gain of 4.82%, outperforming its sector and broader market indices.

JFL Life Sciences Hits Upper Circuit Amidst Unprecedented Buying Interest

2025-12-05 13:26:12

JFL Life Sciences Ltd witnessed extraordinary buying momentum on 5 Dec 2025, hitting the upper circuit with only buy orders in the queue and no sellers present. This rare market phenomenon signals intense demand and the possibility of a multi-day circuit scenario, drawing significant attention from investors and market watchers alike.

JFL Life Sciences Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-25 15:31:01

JFL Life Sciences Ltd has encountered significant selling pressure, with the stock registering a sharp decline and exhibiting a complete absence of buyers on the trading day. The pharmaceutical and biotechnology company’s shares have been under sustained downward momentum, reflecting distress selling signals and a challenging market environment.

Why is JFL Life falling/rising?

2025-11-22 01:28:36

Recent Price Movement and Market Comparison

JFL Life Sciences has experienced a sharp downturn in its stock price over the past year, with a decline of 62.96%, starkly contrasting with the Sensex’s gain of 11.64% during the same period. The stock’s performance over three years is even more concerning, showing a 70.24% loss while the benchmark index surged by 43.55%. This persistent underperformance highlights investor scepticism about the company’s growth prospects and operational efficiency.

In the short term, the stock has also struggled, falling 6.72% in the last week compared to a modest 0.61% rise in the Sensex. Despite a slight positive return of 1.63% over the past month, this is only marginally better than the benchmark’s 0.77% gain, indicating limited investor...

JFL Life Sciences Hits Lower Circuit Amid Heavy Selling Pressure

2025-11-21 11:00:15

Shares of JFL Life Sciences Ltd plunged to their lower circuit limit on 21 Nov 2025, reflecting intense selling pressure and a sharp decline of 5.04% in a single trading session. The stock closed at ₹12.25, matching its intraday low and moving closer to its 52-week low, signalling heightened investor caution in the Pharmaceuticals & Biotechnology sector.

JFL Life Sciences Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-21 10:50:56

JFL Life Sciences Ltd is experiencing severe selling pressure, with the stock hitting a lower circuit and an absence of buyers on the trading floor. The pharmaceutical and biotechnology company’s shares have recorded consecutive losses across multiple time frames, signalling distress selling and a challenging market environment.

JFL Life Sciences Hits Lower Circuit Limit, Closes at Rs 12.75 Amid Decline

2025-11-17 10:00:32

JFL Life Sciences Ltd faced notable trading activity as its stock hit the lower circuit limit, closing at Rs 12.75. The total traded volume was 0.06 lakh shares, with a significant decline in investor participation. The stock is currently underperforming compared to its sector and trading below key moving averages.

How has been the historical performance of JFL Life?

2025-11-13 00:36:37

Answer: The historical performance of JFL Life shows a significant upward trend in net sales and profitability over the years. Breakdown: JFL Life's net sales have increased from 30.17 Cr in Mar'20 to 82.04 Cr in Mar'25, reflecting a strong growth trajectory. Total operating income followed a similar pattern, rising from 30.17 Cr in Mar'20 to 82.04 Cr in Mar'25. The raw material costs also rose, from 26.72 Cr in Mar'20 to 66.77 Cr in Mar'25, indicating increased production expenses. Operating profit, excluding other income, improved from 1.86 Cr in Mar'20 to 8.19 Cr in Mar'25, while profit before tax increased from 0.50 Cr to 6.14 Cr in the same period. Profit after tax also saw a rise from 0.36 Cr in Mar'20 to 4.16 Cr in Mar'25. The company's total assets grew from 48.26 Cr in Mar'22 to 71.91 Cr in Mar'25, with total liabilities increasing from 48.26 Cr to 71.91 Cr. Cash flow from operating activities sho...

How has been the historical performance of JFL Life?

2025-11-13 00:01:57

Answer: The historical performance of JFL Life shows a significant growth trend in net sales and profitability over the past few years. Breakdown: JFL Life's net sales have increased from 30.17 Cr in Mar'20 to 82.04 Cr in Mar'25, indicating a robust growth trajectory. Total operating income has followed a similar pattern, rising from 30.17 Cr to 82.04 Cr during the same period. The company's total expenditure, excluding depreciation, has also grown, reaching 73.85 Cr in Mar'25 from 28.31 Cr in Mar'20. Operating profit, which reflects the company's operational efficiency, has improved from 1.86 Cr in Mar'20 to 8.20 Cr in Mar'25, while profit before tax has increased from 0.50 Cr to 6.14 Cr in the same timeframe. Profit after tax has also seen a rise from 0.36 Cr in Mar'20 to 4.16 Cr in Mar'25. The company's earnings per share (EPS) have fluctuated, peaking at 10.8 in Mar'21 before settling at 1.26 in Mar'25...

View All News